Type I Diabetes Clinical Trial
— DICEOfficial title:
Diabetes Inspired Culinary Education
Verified date | December 2021 |
Source | Case Western Reserve University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to assess the feasibility and efficacy of a community-based culinary nutrition education program (Diabetes Inspired Culinary Education, DICE) on improving the diabetes management and dietary intake of 6-14 year old children with type I diabetes mellitus (TIDM).
Status | Completed |
Enrollment | 22 |
Est. completion date | November 21, 2019 |
Est. primary completion date | November 21, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years and older |
Eligibility | Inclusion Criteria: - Children: 6-14 years old; diagnosed with type I diabetes within the past 5 years; English speaking - Adults: primary caregiver of a 6-14 year old child diagnosed with type I diabetes within the past 5 years; English speaking Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
United States | Dave's Grocery Store and Teaching Kitchen | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
Case Western Reserve University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | % Change in Hemoglobin A1c | Blood glucose/diabetes management | Baseline/pretest, 3 months/posttest | |
Secondary | Change in daily servings of fruit | Daily fruit intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool | Baseline/pretest, 3 months/posttest | |
Secondary | Change in daily servings of vegetables | Daily vegetable intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool | Baseline/pretest, 3 months/posttest | |
Secondary | Change in daily servings of whole grains | Daily whole grain intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool | Baseline/pretest, 3 months/posttest | |
Secondary | Change in daily servings of sugar-sweetened beverages | Daily sugar-sweetened beverage intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool | Baseline/pretest, 3 months/posttest | |
Secondary | Change in daily total caloric intake | Daily caloric intake assessed via 3, 24-hour dietary recalls collected electronically using the Automated Self-Assessment 24-hour (ASA-24) dietary assessment tool | Baseline/pretest, 3 months/posttest | |
Secondary | Change in primary caregiver body mass index (kg/m2) | Assessment of weight status using calibrated stadiometer and electronic scale. | Baseline/pretest, 3 months/posttest | |
Secondary | Change in child body mass index z-score | Assessment of weight status using calibrated stadiometer and electronic scale. | Baseline/pretest, 3 months/posttest | |
Secondary | Change in child blood pressure z-score | Includes systolic and diastolic blood pressure z-scores | Baseline, 3 months, 6 months, 9 months | |
Secondary | Change in child food preparation attitude, self-efficacy and frequency of involvement | Scale 0-132 (higher score indicates more positive attitude, higher self-efficacy, greater frequency of involvement) | Baseline/pretest, 3 months/posttest | |
Secondary | Change in child adherence to TIDM management regimen score | Assessed via Diabetes Management Questionnaire - Scale of 14-70 (higher score indicating greater adherence to management regimen) | Baseline/pretest, 3 months/posttest | |
Secondary | Change in child quality of life score | Assessed via Diabetes Quality of Life for Youth questionnaire - Scale of 41-205 (higher score indicating better quality of life) | Baseline/pretest, 3 months/posttest | |
Secondary | Change in primary caregiver self-efficacy for diabetes management score | Assessed via Maternal Self-Efficacy for Diabetes Management Scale - Scale of 8-40 (higher score indicating greater self-efficacy for diabetes management) | Baseline/pretest, 3 months/posttest | |
Secondary | Change in primary caregiver self-efficacy for healthy meal planning and eating score | Assessed via Parent Mealtime Self-Efficacy Questionnaire - Scale of 11-55 (higher score indicating greater self-efficacy for healthy meal planning and eating) | Baseline/pretest, 3 months/posttest |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT05035368 -
Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT01928329 -
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
|
Phase 2 | |
Completed |
NCT02127762 -
The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy
|
N/A | |
Completed |
NCT00999375 -
Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)
|
Phase 2 | |
Completed |
NCT04279613 -
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041
|
Phase 1 | |
Not yet recruiting |
NCT02117518 -
Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients
|
N/A | |
Withdrawn |
NCT01477476 -
Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes
|
Phase 2 | |
Terminated |
NCT01308437 -
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
|
Phase 3 | |
Terminated |
NCT01652911 -
A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT06242548 -
How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at Altitude
|
N/A | |
Completed |
NCT00351650 -
Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan
|
N/A | |
Withdrawn |
NCT00361608 -
Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device
|
N/A | |
Terminated |
NCT03653533 -
Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump
|
N/A | |
Completed |
NCT00340639 -
Management of Type 1 Diabetes Among Adolescents
|
N/A | |
Completed |
NCT02634216 -
Effects of Capros in Patients With Type-1 Diabetes
|
N/A | |
Completed |
NCT02002130 -
The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
|
Phase 1 | |
Withdrawn |
NCT01623388 -
Epigenetic Modifications of Diabetes Mellitus Type I
|
N/A | |
Completed |
NCT02612493 -
Obesity and Metabolic Surgery in Patients With Type I Diabetes
|
N/A | |
Completed |
NCT01843114 -
Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects
|
N/A | |
Withdrawn |
NCT01398670 -
Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics
|
Phase 3 |